Welcome back to our course on acromegaly. In the previous lesson, we conducted a detailed survey of the external physical manifestations that define the classic acromegalic phenotype. You learned how chronic growth hormone (GH) and insulin-like growth factor 1 (IGF-1) excess remodels bone, cartilage, and soft tissues, leading to the characteristic changes in the face, hands, and skin.
Now, we will turn our attention from the visible exterior to the internal systems. This lesson addresses the major systemic complications of acromegaly, which are the primary determinants of patient morbidity and mortality. While the physical features are striking, it is the profound impact on the cardiovascular, metabolic, and respiratory systems that makes acromegaly a life-threatening condition if left untreated. By the end of this lesson, you will be able to summarize these complications and understand their contribution to the overall disease burden.
A Systemic Disease
The reason acromegaly has such widespread effects is straightforward: GH and IGF-1 receptors are expressed on nearly every cell type in the body. Consequently, no organ system is spared from the consequences of their prolonged overstimulation. The typically long delay between disease onset and diagnosis—often a decade or more—means that many of these complications are well-established by the time a patient receives a diagnosis.
The image below provides a powerful overview of the multi-organ involvement in acromegaly, illustrating the breadth of complications we will discuss.
To begin, let's watch a concise summary that highlights the most significant internal complications associated with GH excess.
Gigantism & Acromegaly | Growth Hormone, Signs & Symptoms, Diagnosis, Treatment
This video from JJ Medicine provides a clear overview of the clinical features, including the systemic complications that drive morbidity.
Please watch the section covering systemic complications. Pay close attention to the list of affected organs and the mention of comorbidities like heart disease, hypertension, and diabetes.
As the video outlines, the list of potential complications is long. We will now explore the three most clinically significant categories in greater detail: cardiovascular, metabolic, and respiratory.
1. Cardiovascular Complications
Cardiovascular disease is the leading historical cause of excess mortality in patients with acromegaly. The constant exposure to high levels of GH and IGF-1 leads to a specific "acromegalic cardiomyopathy" and other vascular issues.
The following reading from The Lancet Diabetes & Endocrinology provides a detailed clinical description of these cardiovascular effects.
[PDF] Acromegaly: pathogenesis, diagnosis, and management - BINASSS
This review article offers a state-of-the-art summary of acromegaly's complications. This section focuses specifically on the cardiovascular system.
In the "Complications" section, please find the subsection "Cardiovascular complications." Read this entire subsection, starting from the beginning. Focus on understanding the pathophysiology and prevalence of: Hypertension Hypertrophic cardiomyopathy and diastolic dysfunction Arrhythmias and valvular disease
Let's synthesize the key points from the reading:
- Hypertension: This affects up to half of all patients. The primary mechanism involves GH-mediated activation of the epithelial sodium channel (ENaC) in the kidneys, leading to sodium and water retention and subsequent volume expansion.
- Acromegalic Cardiomyopathy: This is a distinct entity characterized by biventricular concentric hypertrophy. Both myocardial cells and connective tissue proliferate, leading to a thickened, stiff heart muscle. Initially, systolic function may be preserved or even enhanced (hyperkinetic phase), but this often progresses to diastolic dysfunction, where the ventricles cannot relax and fill properly. In late stages, this can lead to congestive heart failure.
- Arrhythmias and Valvular Disease: Atrial fibrillation can occur, often secondary to the structural changes like atrial dilation. Valvular dysfunction, particularly aortic and mitral regurgitation, is also more common, with disease duration being a significant risk factor.
Importantly, while some of these changes (like left ventricular mass) can regress with successful biochemical control of the disease, established dysfunction, especially heart failure, is often irreversible.
2. Metabolic Complications
Chronic GH excess profoundly disrupts glucose and lipid metabolism. GH is a potent counter-regulatory hormone to insulin, and its overproduction creates a state of significant insulin resistance.
The next reading provides a clear, pathophysiology-focused explanation of how acromegaly leads to diabetes.
Acromegaly Pathophysiology - Rare Disease Advisor
This article from the Rare Disease Advisor breaks down the mechanisms behind the key comorbidities in acromegaly.
Please read the section titled Diabetes Pathophysiology. As you read, focus on how GH excess: Inhibits insulin signaling. Promotes lipolysis, increasing circulating free fatty acids (FFAs). Leads to insulin resistance through the action of these FFAs on skeletal muscle.
As explained in the text, the key mechanism is GH-induced insulin resistance. GH antagonizes insulin's action at several levels: it decreases glucose uptake in peripheral tissues (like muscle) and stimulates hepatic gluconeogenesis. Furthermore, by promoting lipolysis, it floods the circulation with FFAs, which themselves worsen insulin resistance in muscle. The result is that the pancreas must hypersecrete insulin to maintain euglycemia. When this compensatory mechanism fails, impaired glucose tolerance and overt type 2 diabetes mellitus develop, affecting approximately 30-50% of patients. Dyslipidemia, particularly hypertriglyceridemia, is also common.
3. Respiratory Complications
Respiratory issues, primarily obstructive sleep apnea (OSA), are extremely common and contribute significantly to poor quality of life and cardiovascular risk.
[PDF] Acromegaly: pathogenesis, diagnosis, and management - BINASSS
We return to The Lancet review to examine the respiratory effects of acromegaly.
Please read the subsection on respiratory issues. Note the contributing factors to both obstructive and central sleep apnea.
The pathophysiology of OSA in acromegaly is a direct extension of the physical changes we discussed in the last lesson. Airway narrowing occurs due to:
- Macroglossia: Enlargement of the tongue.
- Soft tissue hypertrophy: Swelling of the pharyngeal and laryngeal tissues.
- Mandibular overgrowth (Prognathism): Alteration of the upper airway anatomy.
This combination leads to frequent airway collapse during sleep. Central sleep apnea, where the brain fails to send proper signals to the muscles that control breathing, is also more prevalent. These sleep-disordered breathing patterns result in intermittent hypoxia, which further exacerbates hypertension and cardiovascular strain.
Impact on Morbidity and Mortality
The culmination of these systemic complications is a significant increase in both morbidity (illness and poor quality of life) and mortality (reduced lifespan). Untreated acromegaly is not a benign condition.
Our final reading examines the data on mortality and how it has evolved with modern treatment.
[PDF] Acromegaly: pathogenesis, diagnosis, and management - BINASSS
This final section of the review article quantifies the impact of acromegaly on lifespan.
Please read the section titled Mortality. Focus on the standardized mortality ratio and how the causes of death have shifted over time.
Historically, mortality in patients with acromegaly was roughly double that of the general population, with cardiovascular and respiratory diseases being the primary causes of death. The good news is that with effective multimodal treatment—surgery, medical therapy, and management of comorbidities—this excess mortality can be largely normalized. As patients live longer, however, there has been a noticeable shift in the causes of mortality, with cancer-related deaths becoming more prominent. This is partly due to the pro-proliferative effects of GH and IGF-1, which increase the risk of neoplasms, most notably colon polyps and colorectal cancer.
Conclusion
In this lesson, we have explored the serious internal consequences of chronic GH/IGF-1 excess. Beyond the visible physical changes, acromegaly is a systemic disease that profoundly affects multiple organ systems.
Key Takeaways:
- The systemic complications of acromegaly are due to the ubiquitous expression of GH and IGF-1 receptors throughout the body.
- Cardiovascular complications, including hypertension and a specific hypertrophic cardiomyopathy, have historically been the main driver of mortality.
- Metabolic complications, chiefly insulin resistance and diabetes mellitus, are highly prevalent due to the counter-regulatory effects of GH.
- Respiratory complications, especially obstructive sleep apnea, are common and contribute to cardiovascular strain and reduced quality of life.
- Untreated acromegaly is associated with a twofold increase in mortality. However, successful biochemical control of the disease and management of comorbidities can restore a normal life expectancy.
Now that we have a thorough understanding of the clinical presentation of acromegaly—both its physical signs and its systemic complications—we are equipped to discuss how to formally diagnose the condition. In our next lesson, we will begin our exploration of the diagnostic pathway, starting with initial biochemical screening.